Bicara Therapeutics Inc. Common Stock (BCAX) — Long-term Investment Intensity

Latest as of September 2025: 27.6%

Bicara Therapeutics Inc. Common Stock (BCAX) has a Long-term Investment Intensity of 27.6% as of September 2025. Long-term investments of $117.42 Million represent 27.6% of total assets of $424.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of Bicara Therapeutics Inc. Common Stock to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

27.6%
LT Investments / Total Assets

Long-term Investments

$117.42 Million
USD

Total Assets

$424.69 Million
USD

Country

USA
NASDAQ

Annual Long-term Investment Intensity for Bicara Therapeutics Inc. Common Stock (None–None)

The table below presents the year-by-year Long-term Investment Intensity for Bicara Therapeutics Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read BCAX total liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
pp = percentage points